RA RA
Company Profile ↓Company Overview
RA (RA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +2.86% |
| 6 Months: | +1.76% |
| 3 Months: | +1.43% |
| 1 Month: | -2.04% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)38.03 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 102.85M | 263.32M | -3.57M | 73.37M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -106.67M | -266.33M | 5.57M | -73.89M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 102.85M | 263.32M | -3.57M | 73.37M |
| Net Change in Cash | - | -3.82M | -3.01M | 2.00M | -518.20K |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RA
Spyre Therapeutics (SYRE) Reports RA Trial Results, Is The Stock Overvalued? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOV2lIaEtLVjJ3eHJ4bHRIT05jdVFyblh0TnQzanlYcUlzMTgyY0ZQaUJianRHdGRSdTN1REhPWEhvTDc2Qm9Ta1J6d1pVWHNBMXFDbjhUYlNhUU9PelB6ZUwycWEwaWxLWjktaEF2Q0ctRzhvaWJMd2drMzVvUXZPVF9ZMWd6UFhGcEtDcV…
SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPNFVhVm9pSlVMTXhLd3FHZDRoY3hsMGJnMlR2TkpLZGtmYlhpWFNtSndZbVMtREpRclVsYUlfZURKZjlOSU5oYVhDejYzU2R2cnl2UDVSU3AwaGJHNlEyMmROUmZqN216SHp1b3JjbW9VMUJuVGktM2VZa3RyT1hFaGVfbE1oa0x0bWZRSW…
Stifel reiterates Spyre stock Buy rating after RA study results - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWVd4cVRFcXI0TmFZSFBlMURON2VKY1ZpVGFkbmRhOHJFdVVMbzBwSUlzZ1hnNzdRN0hNempFTGwxM3dYRVVRUWU5ZzE1bVFaV3hpQWpRQUxGTkVZTjRDRko3Rm5rZFNHd0paRGhFY05hTlQ2Qk5mX1dpUi1HUEhfZ3g4LU9iN04zTHFXN0…
Good Old GE Stock Ready For Liftoff? Ra Party (Sw2Xs5k0Ep) - Mshale
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFAwZkZLekhDZzg0Y1VpTHBSZng4QVdoMndOeXBURV9lam9KM1AtLUxyLWpQejV6cE5WZVA2YWpZTzZMYW1Wb2wwZDdzanZPb0Nfd0VhRERlRlBkZHM?oc=5" target="_blank">Good Old GE Stock Ready For Liftoff? Ra Part…
Karyopharm Announces $30 Million Private Placement with RA Capital - PR Newswire
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPWXltbXltM2tBbm1QLUpWZmpQYXB2LS0wb1RhXzlwRl9YY2ZPTnpidGpOXzI2R2FNRk5MdDE1RWJtTlBhM3dDb3dwdWR5UW5RbERUMjlOTU9oQ0E5eHdmRnRkOEd0Ymx0RTF4R21IWkt2cFd0cmZDVmk4VkNmY0ViT1Uwby1WMzU1SVpyYW…
Vor Biopharma (VOR) RA Capital-linked option yields 1,500 shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNcU5iSUFwdmZDM2FSTWJyRFhPSXlTUzJ0WDdoS3dWMjcxRWZjZXVwazVmRnMzeWN1ODJxZGlzaUJaaksyamhQRXN0RVRhaDZwLWpIWmpoUE5BRVdDWV94bk83bEVOcmpybXp4UkFkMmdvMlYxQXdQem9FeXBlY2tTM2k2Vk5iOVB2OXdwX1…
RA — Frequently Asked Questions
What is the current share price of RA?
As of 2026-09-07 16:24 PDT, RA trades at $12.51 on NASDAQ/NYSE. Its 52-week range is $11.83 to $12.86.
Is RA a good stock to buy?
This page provides a data-driven analysis of RA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.